Access cutting-edge covid-19 vaccines treatment through this phase 3 clinical trial at a research site in Bardstown. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Bardstown location
Preparing your pre-screening questions…
Access covid-19 vaccines specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 vaccines treatment provided free
Check if you qualify for this covid-19 vaccines clinical trial in Bardstown, KY
No-Cost Study Care
Local to Bardstown
Convenient for KY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to learn about the safety and effects of updated COVID-19 vaccines (called BNT162b2) in participants 5 Through 64 Years of Age with risk factors for Severe COVID-19, and Participants 65 Years of Age and Older. This study is seeking participants who: * are medically stable * have not had a recent COVID-19 infection or a recent COVID-19 vaccination * have not received certain routine vaccines recently * participants that are 5 through 64 years of age will need to have at least 1 medical condition that increase their risk of complications from COVID-19. Participants in Cohort 1 of this study will receive a single age-appropriate dose (30 mcg for participants aged ≥12 years; 10 mcg for participants aged 5-11 years) of BNT162b2 vaccine 1 which targets COVID-19 (2026/2027 recommended strain) injected in the upper arm. The study team and participants will know which injection they receive. Participants in Cohort 2 of this study will randomly receive 1 injection into their upper arm of either: BNT162b2 vaccine 1; BNT162b2 vaccine 2, or BNT162b2 vaccine 3 which targets COVID-19. The study team and participants will not know which injection they receive. Participants will be in the study for about 6 months and will have at least 3 study visits. Participants will record side effects and complete diaries following visit procedures. For Cohort 1 the study team will collect a nose swab and blood samples at 2 of the 3 visits. For Cohort 2 the study team will collect a nose swab and blood samples at all of the visits.
Sponsor: BioNTech SE
Yes, this clinical trial (NCT07798648) has an active research site in Bardstown, KY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for covid-19 vaccines treatment options in Bardstown, KY, this clinical trial (NCT07798648) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Bardstown research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced covid-19 vaccines specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all covid-19 vaccines clinical trials near you to find additional studies recruiting in your area.
See all covid-19 clinical trials recruiting in Bardstown — not just this study.
Browse COVID-19 Trials in Bardstown →